Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9745)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 27, 2015 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bunchorntavakul C, Maneerattanaporn M, Chavalitdhamrong D. Management of patients with hepatitis C infection and renal disease. World J Hepatol 2015; 7(2): 213-225 [PMID: 25729476 DOI: 10.4254/wjh.v7.i2.213] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v7/i2/213.htm |
| Number | Citing Articles |
| 1 |
Eva M. Teegen, Michael Dürr, Max M. Maurer, Franziska Eurich, Antonia Vollbort, Brigitta Globke, Marcus Bahra, Hendrik Blaeker, Johann Pratschke, Dennis Eurich. Evaluation of histological dynamics, kidney function and diabetes in liver transplant patients after antiviral treatment with direct‐acting antivirals: Therapy of HCV‐recurrence. Transplant Infectious Disease 2019; 21(1) doi: 10.1111/tid.13020
|
| 2 |
Maria A. Sorbera, Michelle L. Friedman, Rebecca Cope. New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment. Journal of Pharmacy Practice 2017; 30(3): 359 doi: 10.1177/0897190016632128
|
| 3 |
Jeonghwan Lee, Jang-Hee Cho, Jong Soo Lee, Dong-Won Ahn, Chan-Duck Kim, Curie Ahn, In Mok Jung, Duck Jong Han, Chun Soo Lim, Yon Su Kim, Young Hoon Kim, Jung Pyo Lee. Pretransplant Hepatitis B Viral Infection Increases Risk of Death After Kidney Transplantation. Medicine 2016; 95(21): e3671 doi: 10.1097/MD.0000000000003671
|
| 4 |
Anna Maruyama, Nilufar Partovi, Eric M. Yoshida, Siegfried R. Erb, Vladimir Marquez Azalgara, Trana Hussaini. A review of direct-acting antivirals for the treatment of hepatitis C in patients with advanced chronic kidney disease. Nephrology Dialysis Transplantation 2015; : gfv361 doi: 10.1093/ndt/gfv361
|
| 5 |
Christophe Hézode, Piero L. Almasio, Stefan Bourgeois, Peter Buggisch, Ashley Brown, Moises Diago, Yves Horsmans, Lawrence Serfaty, Ferenc Szalay, Giovanni B. Gaeta, Ramon Planas, Michael Schlag, Isabelle Lonjon‐Domanec, Edmund Omoruyi, Ralph DeMasi, Stefan Zeuzem. Simeprevir and daclatasvir for 12 or 24 weeks in treatment‐naïve patients with hepatitis C virus genotype 1b and advanced liver disease. Liver International 2017; 37(9): 1304 doi: 10.1111/liv.13376
|
| 6 |
Parmvir Parmar, Curtis Cooper. Management of hepatitis C in a patient undergoing solid organ (kidney) transplant. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2018; 3(4): 231 doi: 10.3138/jammi.2017-0009
|
| 7 |
Jose D. Debes, Paola Ricci. Acute liver failure during hepatitis C treatment with sofosbuvir and ledipasvir. Digestive and Liver Disease 2015; 47(12): 1091 doi: 10.1016/j.dld.2015.08.016
|
| 8 |
Fayda Ibrahim Abdel Motaleb, Enas Samir Nabih, Sherif Moneir Mohamed, Nehal Samir Abd Elhalim. Up-regulation of circulating miRNA146a correlates with viral load via IRAK1 and TRAF6 in hepatitis C virus-infected patients. Virus Research 2017; 238: 24 doi: 10.1016/j.virusres.2017.05.026
|
| 9 |
Tim Mitchell, Aron Chakera, Gary P Jeffrey, Leon A Adams, George Garas, Tamara Jones, Gerry MacQuillan. Reversal of end‐stage renal failure using direct‐acting antiviral agents for chronic hepatitis C. Medical Journal of Australia 2016; 205(5): 205 doi: 10.5694/mja16.00207
|
| 10 |
Adriana Dejman, Marco A. Ladino, David Roth. Treatment and management options for the hepatitis C virus infected kidney transplant candidate. Hemodialysis International 2018; 22(S1) doi: 10.1111/hdi.12646
|
| 11 |
Bengü Tatar, Şükran Köse, Murat Sayan. Outbreak of hepatitis C virus infection in hemodialysis unit. Akademik Gastroenteroloji Dergisi 2019; : 1 doi: 10.17941/agd.662463
|
| 12 |
Noha Mohamed Hany, Abd‐El‐Rahman M. A. Hammouda, Enas Samir Nabih, Sherif Moneir Mohamed. The potential regulatory role of miR16 to the interplay between interferon and transforming growth factor beta pathways through IRF3 and SMAD7 in hepatitis C virus infected patients. Journal of Cellular Biochemistry 2019; 120(8): 12694 doi: 10.1002/jcb.28537
|
| 13 |
C. Martin-Gandul, N.J. Mueller, M. Pascual, O. Manuel. The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation. American Journal of Transplantation 2015; 15(12): 3024 doi: 10.1111/ajt.13486
|
| 14 |
Paul J. Pockros, K. Rajender Reddy, Parvez S. Mantry, Eric Cohen, Michael Bennett, Mark S. Sulkowski, David E. Bernstein, Daniel E. Cohen, Nancy S. Shulman, Deli Wang, Amit Khatri, Manal Abunimeh, Thomas Podsadecki, Eric Lawitz. Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease. Gastroenterology 2016; 150(7): 1590 doi: 10.1053/j.gastro.2016.02.078
|
| 15 |
Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique. Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function. Clinical and Molecular Hepatology 2017; 23(4): 316 doi: 10.3350/cmh.2016.0087
|
| 16 |
Bengu Tatar, Şükran Köse, Nadide Colak Ergun, Melda Turken, Yusuf Onlen, Yusuf Yılmaz, Sıla Akhan. Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience. Revista da Associação Médica Brasileira 2019; 65(12): 1470 doi: 10.1590/1806-9282.65.12.1470
|
| 17 |
Chalermrat Bunchorntavakul, Tawesak Tanwandee. Treatment of Chronic Hepatitis C in Special Populations. Gastroenterology Clinics of North America 2015; 44(4): 883 doi: 10.1016/j.gtc.2015.06.002
|
| 18 |
María-Carlota Londoño, Mar Riveiro-Barciela, Adriana Ahumada, Raquel Muñoz-Gómez, Mercé Roget, María J. Devesa-Medina, Miguel Ángel Serra, Carmen A. Navascués, Carme Baliellas, Teresa Aldamiz-Echevarría, María L. Gutiérrez, Benjamín Polo-Lorduy, Isabel Carmona, Salvador Benlloch, Lucía Bonet, Javier García-Samaniego, Miguel Jiménez-Pérez, Senador Morán-Sánchez, Ángeles Castro, Manuel Delgado, Francisco Gea-Rodríguez, Ignacio Martín-Granizo, María Luisa Montes, Luís Morano, Manuel A. Castaño, Ignacio de los Santos, Montserrat Laguno, Juan Emilio Losa, Marta Montero-Alonso, Antonio Rivero, Cristina de Álvaro, Amanda Manzanares, Josep Mallolas, Guillermina Barril, Emilio González-Parra, Luisa García-Buey, Yury E. Khudyakov. Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice – Vie-KinD study. PLOS ONE 2019; 14(9): e0221567 doi: 10.1371/journal.pone.0221567
|
| 19 |
Howayda Abd Elhameed Elshinnawy, Iman Ibrahim Sarhan, Ossama Ashraf Ahmed, Meryhan Osama Mohamed, Cherry Reda Kamel. Study the response of Qurevo (ombitasvir, paritaprevir, and ritonavir) in end-stage renal disease patients with hepatitis C virus. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00196-x
|
| 20 |
C. Bunchorntavakul, K. Rajender Reddy. Treat chronic hepatitis C virus infection in decompensated cirrhosis – pre‐ or post‐liver transplantation? the ironic conundrum in the era of effective and well‐tolerated therapy. Journal of Viral Hepatitis 2016; 23(6): 408 doi: 10.1111/jvh.12534
|
| 21 |
Ahmed Yahia Elmowafy, Hanzada Mohamed El Maghrabi, Mohamed Elsayed Mashaly, Khaled Farouk Eldahshan, Lionel Rostaing, Mohamed Adel Bakr. High rate of acute kidney injury in patients with chronic kidney disease and hepatitis C virus genotype 4 treated with direct-acting antiviral agents. International Urology and Nephrology 2019; 51(12): 2243 doi: 10.1007/s11255-019-02316-w
|
| 22 |
Alessio Strazzulla, Giuseppe Coppolino, Concetta Di Fatta, Francesca Giancotti, Giuseppina D’Onofrio, Maria Concetta Postorino, Maria Mazzitelli, Selma Valerie Mammone, Innocenza Gentile, Laura Rivoli, Eleonora Palella, Tiziana Gravina, Chiara Costa, Vincenzo Pisani, Vincenzo De Maria, Giorgio Settimo Barreca, Nadia Marascio, Alfredo Focà, Giorgio Fuiano, Elio Gulletta, Carlo Torti. Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?. World Journal of Hepatology 2016; 8(19): 815-824 doi: 10.4254/wjh.v8.i19.815
|
| 23 |
Marcella Visentini, Carmine Tinelli, Stefania Colantuono, Monica Monti, Serena Ludovisi, Laura Gragnani, Milica Mitrevski, Jessica Ranieri, Elisa Fognani, Alessia Piluso, Massimo Granata, Annalisa De Silvestri, Valeria Scotti, Mario U. Mondelli, Anna Linda Zignego, Massimo Fiorilli, Milvia Casato. Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review. Autoimmunity Reviews 2015; 14(10): 889 doi: 10.1016/j.autrev.2015.05.013
|
| 24 |
Anna Maruyama, Trana Hussaini, Nilufar Partovi, Siegfried R. Erb, Vladimir Marquez Azalgara, Nadia Zalunardo, Neora Pick, Mark Hull, Eric M. Yoshida. Successful Treatment of Hepatitis C with Simeprevir, Sofosbuvir, and Ribavirin in an HIV Coinfected Liver Transplant Patient with Advanced Chronic Kidney Disease. Canadian Journal of Infectious Diseases and Medical Microbiology 2016; 2016: 1 doi: 10.1155/2016/8372835
|
| 25 |
Corinne Isnard Bagnis, Patrice Cacoub. Hepatitis C Therapy in Renal Patients: Who, How, When?. Infectious Diseases and Therapy 2016; 5(3): 313 doi: 10.1007/s40121-016-0116-z
|
| 26 |
Akshanth R. Polepally, Prajakta S. Badri, Doerthe Eckert, Sven Mensing, Rajeev M. Menon. Effects of Mild and Moderate Renal Impairment on Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir, and Ribavirin Pharmacokinetics in Patients with Chronic HCV Infection. European Journal of Drug Metabolism and Pharmacokinetics 2017; 42(2): 333 doi: 10.1007/s13318-016-0341-6
|
| 27 |
Giovana Rossato, Cristiane Valle Tovo, Paulo Roberto Lerias de Almeida. Treatment of chronic hepatitis C in patients with chronic kidney disease with Sofosbuvir-basead regimes. The Brazilian Journal of Infectious Diseases 2020; 24(1): 25 doi: 10.1016/j.bjid.2019.10.011
|
| 28 |
Marco Ladino, Fernando Pedraza, David Roth. Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease. World Journal of Hepatology 2017; 9(19): 833-839 doi: 10.4254/wjh.v9.i19.833
|
| 29 |
Marco Ladino, Fernando Pedraza, David Roth. Hepatitis C Virus Infection in Chronic Kidney Disease. Journal of the American Society of Nephrology 2016; 27(8): 2238 doi: 10.1681/ASN.2016010030
|
| 30 |
Rocío González-Grande, Miguel Jiménez-Pérez, Carolina González Arjona, José Mostazo Torres. New approaches in the treatment of hepatitis C. World Journal of Gastroenterology 2016; 22(4): 1421-1432 doi: 10.3748/wjg.v22.i4.1421
|
| 31 |
Carmen Landaverde, Jennifer Wells, Rebekah Hamner, Janie L. Goldstein. Dual therapy of grazoprevir and elbasvir for the treatment of hepatitis C infection. Expert Review of Gastroenterology & Hepatology 2016; 10(4): 419 doi: 10.1586/17474124.2016.1147346
|